AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Proteomic and Autoantibody Signatures Link Coronary Plaque with ApoB-Related Immune Dysregulation

By Dimayuga PC, Parker S, Chyu KY et al.

Background: Coronary atherosclerosis reflects interactions among lipoproteins, complement, coagulation, and adaptive immunity. We evaluated whether plasma proteomic signatures associated with coronary plaque identify immune pathways linked to ApoB-100 autoantibody responses and future myocardial infarction. Methods: Plasma proteomic data were analyzed in subjects stratified by presence or absence of coronary plaque based on coronary calcium score on CT. An institutional AI application identified differentially expressed proteins and performed pathway analysis. As a validation of pathway analysis, ApoB-100 P210 IgG levels were measured in 113 EISNER subjects, including 23 with myocardial infarction during 13-year follow-up. LDL cross-reactivity, P210 IgG immune complexes, and C3b-bound P210 IgG immune complexes were assessed by ELISA. Results: The initial AI-assisted analysis identified 1535 differentially expressed proteins, including single-peptide identifications; 318 met FDR<0.05. Restricting analysis to proteins with ≥2 peptides identified 50 proteins at FDR<0.05. Twenty-six proteins were elevated in subjects with plaques, with APOB, PON1, and APOA1 as the top 3 candidates by FDR, whereas 24 proteins were higher in plaque-free subjects, with HPT, IGJ, and LAC7 as the top three based on FDR. AI- assisted pathway analysis suggested a significantly lower humoral immunity/immunoglobulin pathway in subjects with plaques (Figure). Based on these findings, we assessed the level of an ApoB-100 related peptide IgG (P210 IgG) in subjects with or without coronary calcium on coronary CT angiogram. P210 IgG levels were lower in subjects with CACS>0 and inversely correlated with LDL among subjects with CACS>0. P210 IgG was preferentially cross-reactive with MDA-LDL, suggesting recognition of cryptic ApoB-100 epitopes exposed by LDL modification. Baseline levels of circulating P210 IgG were lower in subjects experiencing future MI with concomitantly higher LDL level, increased P210 IgG immune complexes, and reduced C3b-bound P210 IgG immune complexes when compared with subjects without experiencing future MI. Conclusions: Coronary plaque was associated with a proteomic profile of reduced immunoglobulin-domain proteins. Reduced P210 IgG, increased P210 IgG immune complexes, and reduced C3b-bound immune complexes in future MI subjects suggest impaired ApoB-related immune complex clearance as a potential mechanism linking humoral immune dysregulation to atherosclerotic risk.

doi.org/10.1161/circ.154.suppl_1.9346Biomarkers

AgingResearch.News